Annette Schlemmer
About
In The Last Decade
Annette Schlemmer
21 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Rheumatology 694
- Orthopedics and Sports Medicine 463
- Oncology 333
- Molecular Biology 258
- Hematology 248
Countries citing papers authored by Annette Schlemmer
This map shows the geographic impact of Annette Schlemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Schlemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Schlemmer more than expected).
Fields of papers citing papers by Annette Schlemmer
This network shows the impact of papers produced by Annette Schlemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Schlemmer. The network helps show where Annette Schlemmer may publish in the future.
Co-authorship network of co-authors of Annette Schlemmer
This figure shows the co-authorship network connecting the top 25 collaborators of Annette Schlemmer. A scholar is included among the top collaborators of Annette Schlemmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Schlemmer. Annette Schlemmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | Tapering and Withdrawal of Biologics or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients with Inflammatory Arthritis:A Systematic Review and Meta-Analyses of Randomised Trials | 1 |
| 4 | 17 | |
| 5 | 17 | |
| 6 | 22 | |
| 7 | 6 | |
| 8 | 12 | |
| 9 | Very High Remission Rates Are Achieved By Methotrexate and Intraarticular Glucocorticoids Independent Of Induction Therapy With Adalimumab; Year 2 Clinical Results Of An Investigator-Initiated Randomised, Controlled Clinical Trial Of Early, Rheumatoid Arthritis (OPERA) | 3 |
| 10 | 145 | |
| 11 | 105 | |
| 12 | Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). | 2 |
| 13 | Adalimumab Added to Methotrexate and Intra-Articular Glucocorticoid Increases Remission Rates At One Year In Early, DMARD-Naïve Patients with Rheumatoid Arthritis—An Investigator-Initiated Randomized, Controlled, Double-Blinded Study | 3 |
| 14 | 419 | |
| 15 | 53 | |
| 16 | 34 | |
| 17 | 79 | |
| 18 | 308 | |
| 19 | 250 | |
| 20 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.